Your browser doesn't support javascript.
loading
Does exercise intensity matter for fatigue during (neo-)adjuvant cancer treatment? The Phys-Can randomized clinical trial.
Demmelmaier, Ingrid; Brooke, Hannah L; Henriksson, Anna; Mazzoni, Anne-Sophie; Bjørke, Ann Christin Helgesen; Igelström, Helena; Ax, Anna-Karin; Sjövall, Katarina; Hellbom, Maria; Pingel, Ronnie; Lindman, Henrik; Johansson, Silvia; Velikova, Galina; Raastad, Truls; Buffart, Laurien M; Åsenlöf, Pernilla; Aaronson, Neil K; Glimelius, Bengt; Nygren, Peter; Johansson, Birgitta; Börjeson, Sussanne; Berntsen, Sveinung; Nordin, Karin.
Afiliação
  • Demmelmaier I; Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.
  • Brooke HL; Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.
  • Henriksson A; Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.
  • Mazzoni AS; Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.
  • Bjørke ACH; Department of Sport Science and Physical Education, University of Agder, Kristiansand, Norway.
  • Igelström H; Department of Neuroscience, Uppsala University, Uppsala, Sweden.
  • Ax AK; Department of Oncology and Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.
  • Sjövall K; Department of Oncology, Skåne University Hospital, Lund University, Lund, Sweden.
  • Hellbom M; Stockholm Health Care Services, Centre for Cancer Rehabilitation, Stockholm, Sweden.
  • Pingel R; Department of Statistics, Uppsala University, Uppsala, Sweden.
  • Lindman H; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Johansson S; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Velikova G; Leeds Cancer Centre, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
  • Raastad T; Department of Sport Science and Physical Education, University of Agder, Kristiansand, Norway.
  • Buffart LM; Department of Physical Performance, Norwegian School of Sport Sciences, Oslo, Norway.
  • Åsenlöf P; Department of Physiology, Radboudumc, Nijmegen, The Netherlands.
  • Aaronson NK; Department of Neuroscience, Uppsala University, Uppsala, Sweden.
  • Glimelius B; Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Nygren P; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Johansson B; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Börjeson S; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Berntsen S; Department of Oncology and Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.
  • Nordin K; Department of Sport Science and Physical Education, University of Agder, Kristiansand, Norway.
Scand J Med Sci Sports ; 31(5): 1144-1159, 2021 May.
Article em En | MEDLINE | ID: mdl-33527488
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Neoadjuvante / Terapia por Exercício / Fadiga / Neoplasias Tipo de estudo: Clinical_trials / Etiology_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Neoadjuvante / Terapia por Exercício / Fadiga / Neoplasias Tipo de estudo: Clinical_trials / Etiology_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article